Navigation Links
IMPAC Medical Systems to Offer Revenue Cycle Inc.'s Array of Oncology Products and Services to Customers
Date:10/28/2007

LOS ANGELES, Oct. 28 /PRNewswire/ -- IMPAC Medical Systems, Inc., an Elekta company, and global leader in oncology information technology solutions, and Revenue Cycle Inc., a comprehensive business-side evaluation, analysis and solutions provider for the oncology market, today announced an agreement under which Revenue Cycle Inc. will offer IMPAC customers oncology specific reimbursement, billing, and coding consulting, as well as auditing and on-site training services. The announcement was made at the 49th Annual Meeting of The American Society for Therapeutic Radiology and Oncology (ASTRO), held October 28 -- November 1 at the Los Angeles Convention Center.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020318/ELEKTALOGO )

"Medical and radiation oncology involve complex and sophisticated treatments, leading to a complex and challenging reimbursement model," says Robert Hubbell, director of Business Development for IMPAC. "Revenue Cycle Inc. provides our customers with the expertise necessary to interpret and comply with ever-changing regulations and procedures, and assists with the practical application of these procedures. The Center for Medicare and Medicaid Services (CMS), for instance, issues new or updated regulations on a regular basis. Revenue Cycle Inc. will help interpret that information for IMPAC customers via on-site training, publications, seminars, and Webinars."

Revenue Cycle Inc. will incorporate its knowledge of MOSAIQ(TM) software into its services for IMPAC customers. "Many of our customers underestimate the economic benefits of using MOSAIQ to its full extent, as far as EMR, scheduling and billing features," says David Nikolai, Business Marketing Manager for IMPAC. One of the goals of this agreement is to help customers optimize their use of the MOSAIQ system by overlaying Revenue Cycle Inc.'s coding and reimbursement expertise with the use of MOSAIQ. By doing this, we enable our users to dramatically improve their reimbursement rates and maximize their return on invested capital. They'll get even more out of their MOSAIQ system when it's combined with Revenue Cycle Inc.'s services."

Located in Austin, Texas (USA), Revenue Cycle Inc. is a nationally recognized consulting firm delivering comprehensive business-side evaluation, analysis and solutions for oncology. Its affiliate company RC Billing is an industry-leading full-spectrum billing resource specializing in radiation and medical oncology. Revenue Cycle Inc. was founded in 2002 to provide oncology and healthcare professionals, practice groups, and hospitals with expert solutions regarding business, financial, and management support, and strategic planning. "We're very excited about working with IMPAC to help their customers successfully address reimbursement related issues, thereby improving efficiency and financial outcomes," says Sally Eggleston, director of Business Development for Revenue Cycle Inc.

About Elekta and IMPAC

Elekta Inc., IMPAC Medical Systems, Medical Intelligence and 3D Line Medical Systems are all part of the Elekta Group, an international medical technology corporation, providing meaningful solutions, comprehensive information systems and services for improved cancer care and management of brain disorders.

All of Elekta's solutions employ non-invasive or minimally invasive techniques and are therefore clinically effective, gentle on the patient and cost-effective. Elekta is listed on the Nordic Exchange under the ticker EKTAb and the company head office is located in Stockholm, Sweden. For additional information, please visit http://www.elekta.com and http://www.impac.com.


'/>"/>
SOURCE IMPAC Medical Systems, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Proposed telecom bill would have Katrina impact
2. Shades of gray: Business impacts of an aging workforce
3. Impact of e-medical records will be felt at home
4. Javas undeniable impact on the Web
5. Impact of research park firms pegged at $680M
6. The flattening world and its impact on U.S. biotech
7. Doyle signs bill that impacts electronic medical records
8. RFID starting to make real impact on business
9. Transition continues to impact Third Wave financials
10. Genzyme acquistion of Bone Care approved, significant impact forecast
11. The impact of ACT 255 on the future of high-tech investment in Wisconsin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... AMRI, ... and biotechnology industries to improve patient outcomes and quality of life, will now ... testing are being attributed to new regulatory requirements for all new drug products, ...
(Date:10/11/2017)... LINDA, CA (PRWEB) , ... October 11, 2017 ... ... to upregulate any gene in its endogenous context, enabling overexpression experiments and avoiding ... (CRISPRa) system with small RNA guides is transformative for performing systematic gain-of-function studies. ...
(Date:10/11/2017)... ... October 11, 2017 , ... Proscia ... be hosting a Webinar titled, “Pathology is going digital. Is your lab ready?” ... pathology adoption best practices and how Proscia improves lab economics and realizes an ...
(Date:10/11/2017)... ... 2017 , ... Disappearing forests and increased emissions are the main causes of ... year. Especially those living in larger cities are affected by air pollution related diseases. ... most pollution-affected countries globally - decided to take action. , “I knew I had ...
Breaking Biology Technology:
(Date:4/5/2017)... Today HYPR Corp. , leading innovator ... of the HYPR platform is officially FIDO® Certified ... architecture that empowers biometric authentication across Fortune 500 enterprises ... over 15 million users across the financial services industry, ... product suites and physical access represent a growing portion ...
(Date:4/3/2017)... WASHINGTON , April 3, 2017 /PRNewswire-USNewswire/ ... single-cell precision engineering platform, detected a statistically ... cell product prior to treatment and objective ... highlight the potential to predict whether cancer ... prior to treatment, as well as to ...
(Date:3/30/2017)... , March 30, 2017 Trends, opportunities ... (physiological and behavioral), by technology (fingerprint, AFIS, iris recognition, ... recognition, and others), by end use industry (government and ... immigration, financial and banking, and others), and by region ... , Asia Pacific , and ...
Breaking Biology News(10 mins):